Eu Ivdd Eu Ivd General No Longer On The Market 🇨🇳 China

Sharay aCL IgA (CLIA)

Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06975070761509
Basic UDI-DI Code
B-06975070761509
Reference
18130001
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
No Longer On The Market

Additional Description

Sharay aCL IgA (CLIA) is intended for the in vitro quantitative measurement of anti-Cardiolipin IgA antibodies in human serum and plasma as an aid in the diagnosis of primary Antiphospholipid Syndrome (APS) and those secondary to systemic lupus erythematosus (SLE) or SLE-like disorders in conjunction with other laboratory and clinical findings.

CND Nomenclature Codes

Code Description
W0102100501 ANTI-CARDIOLIPIN ANTIBODIES

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all